Idiopathic Refractory Scleritis
📧 Sign up to get email alerts when something new happens for Idiopathic Refractory Scleritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2022-07-20Clinical Trial Update: Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS) [Phase 3]
A Phase 3 trial comparing cyclophosphamide vs. infliximab for refractory idiopathic scleritis was withdrawn.